Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Organophosphate and carbamate poisoning

INTRODUCTION

Organophosphates and carbamates are potent cholinesterase inhibitors capable of causing severe cholinergic toxicity following cutaneous exposure, inhalation, or ingestion. Although structurally distinct (figure 1), organophosphates and carbamates exhibit similar clinical manifestations with toxicity and require similar management following overdose.

An overview of organophosphate and carbamate poisoning will be presented here. A summary table to facilitate emergent management is provided (table 1). A general approach to suspected drug intoxication is discussed separately. (See "General approach to drug poisoning in adults".)

EPIDEMIOLOGY AND SOURCES OF EXPOSURE

Organophosphates have been used as insecticides worldwide for more than 50 years. The use of these agents has declined in the last 10 to 20 years, in part due to the development of carbamate insecticides, which are associated with similar toxicities [1]. Medical applications of organophosphates and carbamates include reversal of neuromuscular blockade (neostigmine, pyridostigmine, edrophonium) and treatment of glaucoma, myasthenia gravis, and Alzheimer disease (echothiophate, pyridostigmine, tacrine, and donepezil).

Worldwide, an estimated 3,000,000 people are exposed to organophosphate or carbamate agents each year, with up to 300,000 fatalities [2,3]. In the United States, there were more than 8000 reported exposures to these agents in 2008, resulting in fewer than 15 deaths [4]. Toxicity generally results from accidental or intentional ingestion of, or exposure to, agricultural pesticides [2,5]. Other potential causes of organophosphate or carbamate toxicity include ingestion of contaminated fruit, flour, or cooking oil, and wearing contaminated clothing [5,6]. (See "Information and educational resources for occupational and environmental health issues in the United States".)

Specific agents linked to human poisoning include both carbamate (methomyl and aldicarb) and organophosphate (parathion, fenthion, malathion, diazinon, and dursban) insecticides. Chlorpyrifos, the organophosphate agent of dursban, is found in some popular household roach and ant sprays, including Raid® and Black Flag® (figure 2). The United States Environmental Protection Agency (EPA) banned many household uses of chlorpyrifos in 2001, and has restricted its use on certain crops including tomatoes, apples, and grapes [7].

                  

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jul 2014. | This topic last updated: Jun 23, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Rotenberg M, Shefi M, Dany S, et al. Differentiation between organophosphate and carbamate poisoning. Clin Chim Acta 1995; 234:11.
  2. Eddleston M, Phillips MR. Self poisoning with pesticides. BMJ 2004; 328:42.
  3. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev 2003; 22:165.
  4. Bronstein AC, Spyker DA, Cantilena LR Jr, et al. 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila) 2009; 47:911.
  5. Watson WA, Litovitz TL, Rodgers GC Jr, et al. 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2003; 21:353.
  6. Wu ML, Deng JF, Tsai WJ, et al. Food poisoning due to methamidophos-contaminated vegetables. J Toxicol Clin Toxicol 2001; 39:333.
  7. United States Environmental Protection Agency. Organophosphate pesticide information. www.epa.gov/pesticides/op/chlorpyrifos/consumerqs.htm (Accessed on May 03, 2005).
  8. Buckley NA, Roberts D, Eddleston M. Overcoming apathy in research on organophosphate poisoning. BMJ 2004; 329:1231.
  9. Centers for Disease Control and Prevention (CDC). Recognition of illness associated with exposure to chemical agents--United States, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:938.
  10. Okudera H, Morita H, Iwashita T, et al. Unexpected nerve gas exposure in the city of Matsumoto: report of rescue activity in the first sarin gas terrorism. Am J Emerg Med 1997; 15:527.
  11. Reutter S. Hazards of chemical weapons release during war: new perspectives. Environ Health Perspect 1999; 107:985.
  12. Tafuri J, Roberts J. Organophosphate poisoning. Ann Emerg Med 1987; 16:193.
  13. Khurana D, Prabhakar S. Organophosphorus intoxication. Arch Neurol 2000; 57:600.
  14. Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. QJM 2002; 95:275.
  15. Morgan JP. The Jamaica ginger paralysis. JAMA 1982; 248:1864.
  16. Mutch E, Blain PG, Williams FM. Interindividual variations in enzymes controlling organophosphate toxicity in man. Hum Exp Toxicol 1992; 11:109.
  17. Eddleston M, Eyer P, Worek F, et al. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 2005; 366:1452.
  18. Sidell FR. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol 1974; 7:1.
  19. Sidell FR. Clinical effects of organophosphorus cholinesterase inhibitors. J Appl Toxicol 1994; 14:111.
  20. Wang MH, Tseng CD, Bair SY. Q-T interval prolongation and pleomorphic ventricular tachyarrhythmia ('Torsade de pointes') in organophosphate poisoning: report of a case. Hum Exp Toxicol 1998; 17:587.
  21. Sahin I, Onbasi K, Sahin H, et al. The prevalence of pancreatitis in organophosphate poisonings. Hum Exp Toxicol 2002; 21:175.
  22. Asari Y, Kamijyo Y, Soma K. Changes in the hemodynamic state of patients with acute lethal organophosphate poisoning. Vet Hum Toxicol 2004; 46:5.
  23. Arima H, Sobue K, So M, et al. Transient and reversible parkinsonism after acute organophosphate poisoning. J Toxicol Clin Toxicol 2003; 41:67.
  24. Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 1987; 316:761.
  25. Indira M, Andrews MA, Rakesh TP. Incidence, predictors, and outcome of intermediate syndrome in cholinergic insecticide poisoning: a prospective observational cohort study. Clin Toxicol (Phila) 2013; 51:838.
  26. Karalliedde L, Baker D, Marrs TC. Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy. Toxicol Rev 2006; 25:1.
  27. Groszek B, Pach J, Kłys M. Intermediate syndrome in acute fenitrothion poisoning. Przegl Lek 1995; 52:271.
  28. De Bleecker J, Van den Neucker K, Colardyn F. Intermediate syndrome in organophosphorus poisoning: a prospective study. Crit Care Med 1993; 21:1706.
  29. Moretto A, Lotti M. Poisoning by organophosphorus insecticides and sensory neuropathy. J Neurol Neurosurg Psychiatry 1998; 64:463.
  30. Sevim S, Aktekin M, Dogu O, et al. Late onset polyneuropathy due to organophosphate (DDVP) intoxication. Can J Neurol Sci 2003; 30:75.
  31. Yang PY, Tsao TC, Lin JL, et al. Carbofuran-induced delayed neuropathy. J Toxicol Clin Toxicol 2000; 38:43.
  32. Dickoff DJ, Gerber O, Turovsky Z. Delayed neurotoxicity after ingestion of carbamate pesticide. Neurology 1987; 37:1229.
  33. Glynn P. Neuropathy target esterase. Biochem J 1999; 344 Pt 3:625.
  34. Abou-Donia MB. Organophosphorus ester-induced chronic neurotoxicity. Arch Environ Health 2003; 58:484.
  35. Aygun D, Onar MK, Altintop BL. The clinical and electrophysiological features of a delayed polyneuropathy developing subsequently after acute organophosphate poisoning and it's correlation with the serum acetylcholinesterase. Electromyogr Clin Neurophysiol 2003; 43:421.
  36. Johnson MK. Organophosphorus esters causing delayed neurotoxic effects: mechanism of action and structure activity studies. Arch Toxicol 1975; 34:259.
  37. Craig PH, Barth ML. Evaluation of the hazards of industrial exposure to tricresyl phosphate: a review and interpretation of the literature. J Toxicol Environ Health B Crit Rev 1999; 2:281.
  38. Cavari Y, Landau D, Sofer S, et al. Organophosphate poisoning-induced acute renal failure. Pediatr Emerg Care 2013; 29:646.
  39. Agostini M, Bianchin A. Acute renal failure from organophospate poisoning: a case of success with haemofiltration. Hum Exp Toxicol 2003; 22:165.
  40. Johnson, MK. Mechanisms of and biomarkers for acute and delayed neuropathic effects of organophosphorus esters. In: Use of Biomarkers in Assessing Health and Environmental Impact of Chemical Pollutants. NATO Advanced Study Workshop. June 1-5, 1992, Amaral-Mendes, J, Traviseds, CC (Eds), Plenum Press, Luso, Portugal 1993. p.169.
  41. Konickx LA, Bingham K, Eddleston M. Is oxygen required before atropine administration in organophosphorus or carbamate pesticide poisoning? - A cohort study. Clin Toxicol (Phila) 2014; 52:531.
  42. Eddleston M, Roberts D, Buckley N. Management of severe organophosphorus pesticide poisoning. Crit Care 2002; 6:259.
  43. Abedin MJ, Sayeed AA, Basher A, et al. Open-label randomized clinical trial of atropine bolus injection versus incremental boluses plus infusion for organophosphate poisoning in Bangladesh. J Med Toxicol 2012; 8:108.
  44. United States Food and Drug Administration. FDA approves pediatric doses of Atropen. FDA Talk Paper, www.fda.gov/bbs/topics/ANSWERS/2003/ANS01232.html (Accessed on May 03, 2005).
  45. Newmark J. Therapy for nerve agent poisoning. Arch Neurol 2004; 61:649.
  46. Johnson, MK, Jacobsen, D, Meredith, TJ, et, al. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med 2000; 12:22.
  47. World Health Organization. Environmental Health Criteria No 63. Organophosphorus Pesticides: A General Introduction. World Health Organization, Geneva 1986.
  48. Holstege CP, Baer AB. Insecticides. Curr Treat Options Neurol 2004; 6:17.
  49. Schier JG, Hoffman RS. Treatment of sarin exposure. JAMA 2004; 291:182; author reply 182.
  50. Pawar KS, Bhoite RR, Pillay CP, et al. Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial. Lancet 2006; 368:2136.
  51. Schexnayder S, James LP, Kearns GL, Farrar HC. The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning. J Toxicol Clin Toxicol 1998; 36:549.
  52. Buckley NA, Eddleston M, Li Y, et al. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev 2011; :CD005085.
  53. Eddleston M, Eyer P, Worek F, et al. Pralidoxime in acute organophosphorus insecticide poisoning--a randomised controlled trial. PLoS Med 2009; 6:e1000104.
  54. McDonough JH Jr, Zoeffel LD, McMonagle J, et al. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 2000; 38:1.
  55. Tuovinen K. Organophosphate-induced convulsions and prevention of neuropathological damages. Toxicology 2004; 196:31.
  56. Office of the U.S. Surgeon General. Army's Diazepam Auto-Injector Package Insert. U.S. Army Medical Research and Development Command (MCMR-RCQ-HR) Fort Detrick, Detrick, MD 1997.
  57. Capacio BR, Byers CE, Merk KA, et al. Pharmacokinetic studies of intramuscular midazolam in guinea pigs challenged with soman. Drug Chem Toxicol 2004; 27:95.
  58. Stacey R, Morfey D, Payne S. Secondary contamination in organophosphate poisoning: analysis of an incident. QJM 2004; 97:75.
  59. Geller RJ, Singleton KL, Tarantino ML, et al. Nosocomial poisoning associated with emergency department treatment of organophosphate toxicity--Georgia, 2000. J Toxicol Clin Toxicol 2001; 39:109.
  60. Eddleston M, Juszczak E, Buckley NA, et al. Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial. Lancet 2008; 371:579.
  61. Roberts D, Buckley NA. Alkalinisation for organophosphorus pesticide poisoning. Cochrane Database Syst Rev 2005; :CD004897.
  62. Davies JO, Eddleston M, Buckley NA. Predicting outcome in acute organophosphorus poisoning with a poison severity score or the Glasgow coma scale. QJM 2008; 101:371.
  63. Peter JV, Thomas L, Graham PL, et al. Performance of clinical scoring systems in acute organophosphate poisoning. Clin Toxicol (Phila) 2013; 51:850.